Navigation Links
AMRI Announces First Quarter 2013 Results and Raises EPS Guidance for the Year
Date:5/7/2013

ward-looking statement in this press release to reflect future events or changes in facts assumed for purposes of providing this guidance or otherwise affecting the forward-looking statements contained in this press release.

Non-GAAP Adjustment ItemsTo supplement our financial results prepared in accordance with U.S. GAAP, we have presented non-GAAP measures of income (loss) from operations, net income (loss) and income (loss) per diluted share, as adjusted to exclude certain long-lived asset impairment charges, restructuring charges, lease restructuring charges and insurance demutualization gain in the 2012 and 2013 periods.  Exclusion of these non-recurring items allow comparisons of operating results that are consistent over time.  We believe presentation of these non-GAAP measures enhances an overall understanding of our historical financial performance because we believe they are an indication of the performance of our base business. Management uses these non-GAAP measures as a basis for evaluating our financial performance as well as for budgeting and forecasting of future periods. For these reasons, we believe they can be useful to investors. The presentation of this additional information should not be considered in isolation or as a substitute for income (loss) from operations, net income (loss) or income (loss) per diluted share prepared in accordance with U.S. GAAP.  Reconciliations of these non-GAAP measures to the most directly comparable GAAP financial measures are set forth in Table 1.  Our projected 2013 adjusted EPS, however, is only provided on an adjusted basis.  It is not feasible to provide GAAP EPS guidance because the items excluded are difficult to predict and estimate and are primarily dependent on future events. Albany Molecular Research, Inc.Condensed Consolidated Statements of Operations (unaudited)Three Months Ended(Dollars in thousands, except for per share data)March 31, 2013March 31, 2012Contr
'/>"/>

SOURCE AMRI
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Rigel Announces First Quarter 2013 Financial Results
2. Mindray Announces First Quarter 2013 Financial Results
3. Lilly Announces CEO Dr. John Lechleiter to Undergo Scheduled Surgery
4. Hologic Announces Second Quarter Fiscal 2013 Operating Results
5. Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
6. AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab
7. Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
8. Apollo Medical Holdings Announces Record Fiscal Year-End Results
9. Atrium Medical Announces 1-year results of the INFUSE-AMI Trial
10. Premier Home Medical Supply Vendor Med Supply Shop Announces Drive Spring Promotion
11. Volcano Announces First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage ... pain, announced today that it has appointed Mr. ... Director of Clinical Development. During his extensive ... led successful global clinical operations teams, in the US ... clinical development of numerous therapeutics and diagnostics across a ...
(Date:9/18/2014)... Nev. and ROCKVILLE, Md. ... SPPI ), a biotechnology company with fully ... focus in hematology and oncology, and CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary focus on ...
(Date:9/18/2014)... , September 18, 2014 ... economic growth, and the situation is most likely to deteriorate ... is observing an impact across all sectors in the form ... rise in inflation, limited access to external financing and international ... could experience an increase in payment delays and defaults. ...
Breaking Medicine Technology:Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 2Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 3Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 4Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 5Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 6Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 7Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 8Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 9Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs 10Exporters to Russia Facing Increasing Payment Risk 2
... SeQual Technologies, Inc., a pioneer in portable oxygen technology, ... by Chart Industries, wholly owned subsidiary, CAIRE Inc., a ... care market. SeQual has built a strong reputation based ... a leader in portable oxygen concentrators, SeQual will complement ...
... SRI International, an independent nonprofit research and ... with PhenoMatriX (PMX), a biotechnology company, on the ... cisplatin and related analogues are used to treat ... major weapons against solid tumors and other difficult-to-treat ...
Cached Medicine Technology:SeQual Technologies to be Acquired by Chart Industries 2SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies 2SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies 3SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies 4
(Date:9/18/2014)... (PRWEB) September 18, 2014 ItsHot.com, a ... is now offering a 65-80% discount on its attractive ... whopping 71% off on its 14K Gold Pave Diamond ... band can now be bought for just $775. The ... , Talking about this diamond band, a representative stated, ...
(Date:9/18/2014)... City, UT & Baltimore, MD (PRWEB) September 18, 2014 ... its founder, Frank Davis, are pleased to announce the ... whole-food powder made from the nutrient-rich liquid of young, ... the newest product in the highly-acclaimed Activz Whole-Food Nutrition ... of organic fruit, vegetable and grass options. The ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Throughout their ... cheer each other on, celebrate their achievements and accomplishments ... laughter, heartache and joy. , Joanie’s Sisters in Support, ... for women joined together by their battles against breast ... The group, which was organized in June, meets once ...
(Date:9/18/2014)... understanding the nature of the fight for superiority between ... therapies to combat leukaemia, say researchers from the University ... in Cell Reports , investigated Acute Myeloid Leukaemia ... develop normally into mature blood cells. , Stem cells ... cells each day. The process resembles a production line ...
(Date:9/18/2014)... independent groups of researchers led by Sidney (Wally) ... Charles Lowenstein, MD, of the University of Rochester, ... a gene called STXBP5 plays in the development ... genome-wide association studies (GWAS) identified a gene called ... called Von Willebrand factor (VWF). , VWF is ...
Breaking Medicine News(10 mins):Health News:ItsHot.com Now Offering 65-80% Discount on its Striking Collection of Diamond Wedding Bands 2Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 2Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 3Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 2Health News:Artist’s Cancer Jewelry to Benefit Joanie’s Sisters 3Health News:The war on leukemia: How the battle for cell production could be decisive 2Health News:University of Kentucky research explores STXBP5 gene and its role in blood clotting 2
... secret stash of the virus makes it that much harder ... -- Medications can reduce the level of the AIDS virus ... often roars back when patients stop taking their pills. Now, ... manages to hide and avoid the killing powers of medicine. ...
... between stress and death risk, researchers say , SUNDAY, March ... misery and death has helped researchers identify a gene variant ... U.S. research team focused on a gene called IL6, which ... to cardiovascular disease, neurodegeneration and some types of cancer. , ...
... The Pediatric Cancer ... Annual “Reaching for the Cure” 10K Run, 5K Run/Walk, and 1K Kids’ Fun Run ... Irvine, CA (PRWEB) March 7, ... “Reaching for the Cure” Half Marathon | 10K 5K Run | 5K Walk | ...
... ... Khanna Institute of LASIK and Refractive Surgery. , ... (Vocus) March 6, 2010 -- Khanna Institute of LASIK and Refractive ... Baldwin brothers, 43, attended the fundraiser with his daughter and Alec,s daughter Ireland, 14. The ...
... cuff surgery remains significantly different when compared to the ... In the study, researchers used X-rays providing a ... relation to the shoulder blade, to compared motion in ... repair of tendon tears and no symptoms in their ...
... MO - Breast cancer patients with early stage disease that ... from radiation after mastectomy, because of the low present-day risk ... that could one day change the course of treatment for ... The University of Texas M. D. Anderson Cancer. The ...
Cached Medicine News:Health News:HIV Hides Out in Bone Marrow Cells 2Health News:Gene Variant May Help Some Overcome Adversity 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 2Health News:Sponsors for the 2010 Pediatric Cancer Research Foundation “Reaching for the Cure” Annual Cinco de Mayo Run/Walk Fundraising Event 3Health News:Khanna and Stephen Baldwin Attend Carol M. Baldwin Breast Cancer Research 2Health News:Henry Ford Hospital study: Shoulder function not fully restored after surgery 2Health News:Most early-stage breast cancer patients may not need radiation after mastectomy 2Health News:Most early-stage breast cancer patients may not need radiation after mastectomy 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: